BOSTON and ROLLE, Switzerland - SOPHiA GENETICS  NASDAQ  SOPH , a leader in data-driven medicine, has announced a partnership with Karkinos Healthcare to enhance cancer research and care in India. Dr. R Venkataramanan, Founder and CEO of Karkinos Healthcare, highlighted the partnership's potential to generate world-class research for faster and more accurate cancer diagnosis and management, with a focus on precision medicine for the underprivileged in India.
SOPHiA GENETICS and Karkinos Healthcare have partnered to enhance cancer research and care in India, focusing on precision medicine for the underprivileged. The partnership aims to generate world-class research for faster and more accurate cancer diagnosis and management.